Stock Report

Download full stock data and analysis for free Last Updated: 04-Sep-2026

Stock Rating

Is this stock worth it? Our ratings reveal the truth.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Clear All

Ankur Drugs & Pharma Key Ratios

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

NSE: ANKURDRUGS | BSE: 531683

₹3.65

up-down-arrow ₹-0.15 (-3.95%)

As on 10-Sep-2013IST

Market cap

info icon

₹8 Cr

Revenue (TTM)

info icon

₹143 Cr

P/E Ratio

info icon

--

P/B Ratio

info icon

-0

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue 1.72 -6.00 -39.52 -48.53 -21.10
EBIT -57.13 -15.52 -27.46 -195.63 -214.85
Net Profit -74.03 -11.51 -35.85 -251.46 -241.79
EPS -74.03 -11.51 -35.33 -250.28 -228.39
Book Value -- -- -123.56 -159.68 -178.64
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMMar-12Mar-11
EBIT-Margin info -12.03-2.01-92.91-62.018.86
Net Margin info -60.77-33.81-164.83-181.91-8.33
Return on equity info -107.72-53.42-100.00-328.47-24.48
Return on Capital info 2.326.90---16.035.42
Return on Assets info -5.54-0.79-15.28-18.59-3.77
Debt to Equity (x) info ----3.89-17.124.99

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Mar-12
Mar-11
Mar-10
Mar-09
Ankur Drugs & Pharma
--
-16.03
5.42
17.58
12.20
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

-100.00

Lower than Peers by 110.72

Profit after tax / Average Net worth * 100

Company Name
TTM
Mar-12
Mar-11
Mar-10
Mar-09
Ankur Drugs & Pharma
-100.00
-328.47
-24.48
29.79
15.75
Peer Median
10.72
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

-15.28

Lower than Peers by 21.86

Profit after tax / Average Total assets * 100

Company Name
TTM
Mar-12
Mar-11
Mar-10
Mar-09
Ankur Drugs & Pharma
-15.28
-18.59
-3.77
5.73
3.65
Peer Median
6.58
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

-92.91

Lower than Peers by 105.50

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Mar-12
Mar-11
Mar-10
Mar-09
Ankur Drugs & Pharma
-92.91
-62.01
8.86
17.06
11.40
Peer Median
12.59
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

-164.83

Lower than Peers by 173.59

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Mar-12
Mar-11
Mar-10
Mar-09
Ankur Drugs & Pharma
-164.83
-181.91
-8.33
7.94
3.83
Peer Median
8.76
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

--

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Mar-12
Mar-11
Mar-10
Mar-09
Ankur Drugs & Pharma
--
-161.65
-0.97
10.54
5.96
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

Revenue Growth

-39.52

Lower than Peers by 47.45

Year on year growth in net sales

Company Name
TTM
Mar-12
Mar-11
Mar-10
Mar-09
Ankur Drugs & Pharma
-39.52
-81.63
-22.72
10.58
43.33
Peer Median
7.93
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

-27.46

Lower than Peers by 43.98

Year on year growth in operating profit (EBIT)

Company Name
TTM
Mar-12
Mar-11
Mar-10
Mar-09
Ankur Drugs & Pharma
-27.46
-228.50
-59.86
65.43
11.82
Peer Median
16.52
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

-35.85

Lower than Peers by 53.10

Year on year growth in profit after tax

Company Name
TTM
Mar-12
Mar-11
Mar-10
Mar-09
Ankur Drugs & Pharma
-35.85
-346.89
-179.84
132.12
-41.54
Peer Median
17.25
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

-35.33

Lower than Peers by 45.65

Year on year growth in earnings per share

Company Name
TTM
Mar-12
Mar-11
Mar-10
Mar-09
Ankur Drugs & Pharma
-35.33
-346.89
-179.84
123.40
-60.11
Peer Median
10.32
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

--

--

Year on year growth in book value per share

Company Name
TTM
Mar-12
Mar-11
Mar-10
Mar-09
Ankur Drugs & Pharma
--
-123.56
-22.76
21.33
24.33
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

3.89

Higher than Peers by 3.85

Total debt / Net worth

Company Name
TTM
Mar-12
Mar-11
Mar-10
Mar-09
Ankur Drugs & Pharma
3.89
-17.12
4.99
3.00
2.85
Peer Median
0.04
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

4.28

--

(Short term borrowings / Net worth)

Company Name
TTM
Mar-12
Mar-11
Mar-10
Mar-09
Ankur Drugs & Pharma
4.28
0.48
1.81
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

0.10

Lower than Peers by 1.64

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Mar-12
Mar-11
Mar-10
Mar-09
Ankur Drugs & Pharma
0.10
0.10
0.24
0.65
5.52
Peer Median
1.74
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

0.06

Lower than Peers by 1.11

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Mar-12
Mar-11
Mar-10
Mar-09
Ankur Drugs & Pharma
0.06
0.07
0.07
0.15
3.25
Peer Median
1.18
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

-2.21

Lower than Peers by 9.97

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Mar-12
Mar-11
Mar-10
Mar-09
Ankur Drugs & Pharma
-2.21
-2.81
0.61
2.49
2.09
Peer Median
7.76
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

20.91

Lower than Peers by 4.84

Debtors outstanding / Net Sales * 100

Company Name
TTM
Mar-12
Mar-11
Mar-10
Mar-09
Ankur Drugs & Pharma
20.91
20.96
4.63
5.14
29.12
Peer Median
25.75
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

0.09

Lower than Peers by 0.57

Sales / Average Total Assets

Company Name
TTM
Mar-12
Mar-11
Mar-10
Mar-09
Ankur Drugs & Pharma
0.09
0.09
0.45
0.71
0.95
Peer Median
0.66
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Mar-12
Mar-11
Mar-10
Mar-09
Ankur Drugs & Pharma
--
83.75
20.49
57.28
83.82
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Mar-12
Mar-11
Mar-10
Mar-09
Ankur Drugs & Pharma
--
219.24
93.89
80.74
63.27
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Mar-12
Mar-11
Mar-10
Mar-09
Ankur Drugs & Pharma
--
432.78
172.48
132.93
24.07
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Mar-12
Mar-11
Mar-10
Mar-09
Ankur Drugs & Pharma
--
-129.79
-58.11
5.09
123.01
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Valuation

View Detailed Peer Comparison

Price / Earnings

--

--

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Mar-12
Mar-11
Mar-10
Mar-09
Ankur Drugs & Pharma
--
--
--
4.54
3.46
Peer Median
44.85
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

-0.04

Lower than Peers by 4.39

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Mar-12
Mar-11
Mar-10
Mar-09
Ankur Drugs & Pharma
-0.04
-0.49
0.41
1.23
0.49
Peer Median
4.35
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Mar-12
Mar-11
Mar-10
Mar-09
Ankur Drugs & Pharma
--
--
--
1.11
3.26
Peer Median
0.11
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

-16.77

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Mar-12
Mar-11
Mar-10
Mar-09
Ankur Drugs & Pharma
-16.77
-66.76
9.79
5.86
6.41
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

8

Lower than Peers by 7,845

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Mar-12
Mar-11
Mar-10
Mar-09
Ankur Drugs & Pharma
8
29
101
391
129
Peer Median
7,852
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...